The inflammatory process of SJIA primarily affects T cells whose activation involves a cascade of responses including B cells activation, consumption of complement factors and release of IL-6, IL-1β, Tumour necrosis factor α (TNF-α), and other proinflammatory cytokines. This evidence concerns the gene IL1B and systemic-onset juvenile idiopathic arthritis.